Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

InterAx and Alveus Enter Strategic Research and Licensing Agreement for Metabolic Disease Therapy

Friday, January 16, 2026

InterAx Biotech Ltd and Alveus Therapeutics Inc have entered into a strategic research collaboration and licensing agreement to develop a differentiated smallmolecule therapeutic candidate for metabolic disease

Zydus Lifesciences completes acquisition of Agenus biologics manufacturing assets and launches Zylidac Bio LLC in the US

Friday, January 16, 2026

Zydus Lifesciences Limited has completed the acquisition of biologics manufacturing assets from Agenus Inc following the completion of all required regulatory approvals including clearance from the Committee

International Healthcare Week Returns to Thailand in 2026 with Expanded Industry Reach

Thursday, January 15, 2026

International Healthcare Week returns to Thailand on July uniting pharmaceutical medical device and manufacturing sectors with over exhibitors and visitors

Celltrion Presents Innovative Drug Pipeline and U.S. Manufacturing and R&D Expansion Strategy at 44th J.P. Morgan Healthcare Conference

Wednesday, January 14, 2026

South Korean biopharma leader Celltrion announced plans for IND submissions by and US manufacturing expansion at the JP Morgan Healthcare Conference

Lynk Pharmaceuticals reports positive Phase III topline data for JAK1 inhibitor zemprocitinib in rheumatoid arthritis, advancing Greater China immunology strategy

Monday, January 12, 2026

Lynk Pharmaceuticals has announced positive Phase III topline results in China for its selective JAK inhibitor zemprocitinib in rheumatoid arthritis reinforcing its immunology pipeline and commercialization partnership with Simcere in Greater China

China SXT Pharmaceuticals launches AI insights initiative to modernize traditional Chinese medicine portfolio and market strategy

Friday, January 09, 2026

China SXT Pharmaceuticals has launched a strategic AI insights initiative to optimize its traditional Chinese medicine product portfolio modernize RD decisionmaking and enhance market and clinic deployment across China

Alessa Therapeutics Receives FDA Fast Track Status for Enolen in Localised Prostate Cancer

Friday, January 09, 2026

Alessa Therapeutics a clinicalstage biopharmaceutical company developing local drug delivery technologies for earlystage prostate cancer has received Fast Track designation from the US Food and Drug Administration for Enolen

BeOne Medicines Reports Positive Phase 3 HERIZON-GEA-01 Results for ZIIHERA Plus TEVIMBRA in HER2-Positive Advanced Gastric and Gastroesophageal Adenocarcinoma, Targeting Asian Regulatory Fil

Thursday, January 08, 2026

BeOne Medicines has reported positive Phase HERIZONGEA results for ZIIHERA plus TEVIMBRA and chemotherapy in HERpositive advanced gastric and gastroesophageal adenocarcinoma and plans regulatory submissions in China and other Asian markets

Lonza’s Synaffix and Sidewinder Therapeutics Sign Multi-Target Licence Agreement for Next-Generation Bispecific ADCs

Thursday, January 08, 2026

Synaffix a Lonza company and Sidewinder Therapeutics have entered into a multitarget licensing agreement to support the development of nextgeneration bispecific antibodydrug conjugates ADCs for the treatment of solid tumours

Helix Signs Multi-Year Strategic Collaboration with GSK to Support Precision Medicine Development

Thursday, January 08, 2026

Helix has entered into a multiyear strategic collaboration with GSK to support the development of precision medicine across a broad range of disease areas As part of the agreement GSK will gain access to Helixs expanding GenoSphere cohorts